LHP588 is an oral, brain-penetrant lysine-gingipain (Kgp) inhibitor designed to block the key virulence factor of P. gingivalis
cSCC is one of the most common cancers in the U.S. and globally
Ticagrelor tablets are indicated for to reduce the risk of cardiovascular death and myocardial infarction,
WCK 6777 is the only once-a-day drug in global antibiotic pipeline designed for outpatient parenteral antimicrobial therapy
MVA-BN approved for use against mpox and smallpox in adolescents 12-17 years of age after expedited review with EMA
Approval based on FLAURA2 results which showed Tagrisso plus chemotherapy extended median progression-free survival by nearly 9 months vs. standard of care
There is an urgent need for more therapeutic treatment options for patients with painful osteoarthritis
Vision loss due to Glaucoma can be prevented if it is detected and treated early
The U.S. FDA recently approved Xolair as the first and only medicine for children and adults with one or more food allergies
Sun Pharma is granted rights for marketing Sovateltide in India under the brand name Tyvalzi (Sovateltide)
Subscribe To Our Newsletter & Stay Updated
